SMLR Stock Recent News
SMLR LATEST HEADLINES
PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Semler Scientific, Inc. (“Semler”) (NASDAQ: SMLR) on behalf of the company's long-term investors.
Semler Scientific has pivoted to a Bitcoin treasury strategy, amassing 3,192 BTC in the process, inspired by Strategy's approach. Semler Scientific's $270M in Bitcoin plus $15M in cash nearly covers its $372M market cap, pricing the core med-tech firm at only $87M. Its QuantaFlo business generated $24.4M in free cash flow last year, suggesting a rare 3.6× FCF multiple.
Bitcoin has gained legitimacy as it has achieved mainstream status these days. Even the United States Securities and Exchange Commission (SEC) has acknowledged its legitimacy with the advent of spot Bitcoin exchanged traded funds (ETFs) like iShares Bitcoin Trust NASDAQ: IBIT issued by the world's largest asset manager BlackRock Inc. NYSE: BLK.
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Semler Scientific, Inc. (“Semler”) (NASDAQ: SMLR) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/semler-scientific/ The investigation seeks to determine whether Semler and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions. Semler s.
SANTA CLARA, Calif. , Feb. 18, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the fourth quarter and year ended December 31, 2024.
SANTA CLARA, Calif. , Feb. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, and BTC Yield, a key performance indicator.
SANTA CLARA, Calif. , Jan. 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR) today announced the pricing of its offering of $85.0 million aggregate principal amount of 4.25% convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
SANTA CLARA, Calif. , Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced select preliminary unaudited fourth quarter 2024 financial results and BTC holdings.
SANTA CLARA, Calif. , Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR) today announced that it intends to offer, subject to market conditions and other factors, $75.0 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
SANTA CLARA, Calif. , Jan. 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator.